Literature DB >> 21484080

One hypovolaemic shock…two kinin pathway abnormalities.

Céline Guichon, Bernard Floccard, Brigitte Coppéré, Etienne Hautin, Florence Bagès-Limoges, Olivier Rouvière, Nicole Monnier, Christian Drouet, Bernard Allaouchiche.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21484080     DOI： 10.1007/s00134-011-2225-1

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN： 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  5 in total

Review 1.  Clinical practice. Hereditary angioedema.

Authors:  Bruce L Zuraw
Journal:  N Engl J Med       Date:  2008-09-04       Impact factor: 91.245

2.  Bradykinin receptor 2 antagonist (icatibant) for hereditary angioedema type III attacks.

Authors:  Laurence Bouillet; Isabelle Boccon-Gibod; Denise Ponard; Christian Drouet; Jean Yves Cesbron; Chantal Dumestre-Perard; Nicole Monnier; Joel Lunardi; Christian Massot; Anne Gompel
Journal:  Ann Allergy Asthma Immunol       Date:  2009-11       Impact factor: 6.347

3.  Increased activity of coagulation factor XII (Hageman factor) causes hereditary angioedema type III.

Authors:  Sven Cichon; Ludovic Martin; Hans Christian Hennies; Felicitas Müller; Karen Van Driessche; Anna Karpushova; Wim Stevens; Roberto Colombo; Thomas Renné; Christian Drouet; Konrad Bork; Markus M Nöthen
Journal:  Am J Hum Genet       Date:  2006-10-18       Impact factor: 11.025

4.  Hereditary angioedema caused by missense mutations in the factor XII gene: clinical features, trigger factors, and therapy.

Authors:  Konrad Bork; Karin Wulff; Jochen Hardt; Günther Witzke; Petra Staubach
Journal:  J Allergy Clin Immunol       Date:  2009-05-27       Impact factor: 10.793

5.  Symptoms, course, and complications of abdominal attacks in hereditary angioedema due to C1 inhibitor deficiency.

Authors:  Konrad Bork; Petra Staubach; Alexander J Eckardt; Jochen Hardt
Journal:  Am J Gastroenterol       Date:  2006-02-08       Impact factor: 10.864
  5 in total
  3 in total

1.  An evidence-based review of the potential role of icatibant in the treatment of acute attacks in hereditary angioedema type I and II.

Authors:  Bernard Floccard; Etienne Hautin; Laurence Bouillet; Brigitte Coppere; Bernard Allaouchiche
Journal:  Core Evid       Date:  2012-09-27

2.  Hereditary angioedema: epidemiology, management, and role of icatibant.

Authors:  Aasia Ghazi; J Andrew Grant
Journal:  Biologics       Date:  2013-05-03

3.  Dedicated call center (SOS-HAE) for hereditary angioedema attacks: study protocol for a randomised controlled trial.

Authors:  Nicolas Javaud; Olivier Fain; Isabelle Durand-Zaleski; David Launay; Laurence Bouillet; Anne Gompel; Alain Sobel; Maguy Woimant; Hasina Rabetrano; Tomislav Petrovic; Frédéric Lapostolle; Isabelle Boccon-Gibod; Paul-Georges Reuter; Philippe Bertrand; Brigitte Coppere; Bernard Floccard; Gisele Kanny; Ludovic Martin; Eric Vicaut; Frédéric Adnet
Journal:  Trials       Date:  2016-04-30       Impact factor: 2.279
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.